These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12221661)
21. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study. Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554 [TBL] [Abstract][Full Text] [Related]
22. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Kado DM; Karlamangla AS; Huang MH; Troen A; Rowe JW; Selhub J; Seeman TE Am J Med; 2005 Feb; 118(2):161-7. PubMed ID: 15694902 [TBL] [Abstract][Full Text] [Related]
23. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827 [TBL] [Abstract][Full Text] [Related]
24. Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Sala I; Belén Sánchez-Saudinós M; Molina-Porcel L; Lázaro E; Gich I; Clarimón J; Blanco-Vaca F; Blesa R; Gómez-Isla T; Lleó A Dement Geriatr Cogn Disord; 2008; 26(6):506-12. PubMed ID: 19023204 [TBL] [Abstract][Full Text] [Related]
26. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758 [TBL] [Abstract][Full Text] [Related]
27. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia. Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247 [TBL] [Abstract][Full Text] [Related]
28. Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Hassin-Baer S; Cohen O; Vakil E; Sela BA; Nitsan Z; Schwartz R; Chapman J; Tanne D Clin Neuropharmacol; 2006; 29(6):305-11. PubMed ID: 17095893 [TBL] [Abstract][Full Text] [Related]
29. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Modrego PJ; Ferrández J Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849 [TBL] [Abstract][Full Text] [Related]
30. Vitamin B12, folate, homocysteine and dementia: are they really related? Arioğul S; Cankurtaran M; Dağli N; Khalil M; Yavuz B Arch Gerontol Geriatr; 2005; 40(2):139-46. PubMed ID: 15680498 [TBL] [Abstract][Full Text] [Related]
31. IANA task force on nutrition and cognitive decline with aging. Gillette Guyonnet S; Abellan Van Kan G; Andrieu S; Barberger Gateau P; Berr C; Bonnefoy M; Dartigues JF; de Groot L; Ferry M; Galan P; Hercberg S; Jeandel C; Morris MC; Nourhashemi F; Payette H; Poulain JP; Portet F; Roussel AM; Ritz P; Rolland Y; Vellas B J Nutr Health Aging; 2007; 11(2):132-52. PubMed ID: 17435956 [TBL] [Abstract][Full Text] [Related]
32. Homocysteine and cognitive performance in healthy elderly subjects. Ravaglia G; Forti P; Maioli F; Scali RC; Saccheitti L; Talerico T; Mantovani V; Bianchin M Arch Gerontol Geriatr Suppl; 2004; (9):349-57. PubMed ID: 15207433 [TBL] [Abstract][Full Text] [Related]
34. [Depression and frontal dysfunction: risks for the elderly?]. Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373 [TBL] [Abstract][Full Text] [Related]
35. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292 [TBL] [Abstract][Full Text] [Related]
36. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Barnes DE; Alexopoulos GS; Lopez OL; Williamson JD; Yaffe K Arch Gen Psychiatry; 2006 Mar; 63(3):273-9. PubMed ID: 16520432 [TBL] [Abstract][Full Text] [Related]
37. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Stanger O; Fowler B; Piertzik K; Huemer M; Haschke-Becher E; Semmler A; Lorenzl S; Linnebank M Expert Rev Neurother; 2009 Sep; 9(9):1393-412. PubMed ID: 19769453 [TBL] [Abstract][Full Text] [Related]
39. [Homocysteine and its role in pathogenesis of Parkinson's disease and other neurodegenerative disorders]. Szadejko K; Szabat K; Ludwichowska A; Sławek J Przegl Lek; 2013; 70(7):443-7. PubMed ID: 24167945 [TBL] [Abstract][Full Text] [Related]